Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

From cancer-targeting enzymes to AI-designed editors, CRISPR technology is rapidly evolving into safer, more precise tools for research and therapy. Innovations like ThermoCas9, chromosome silencing ...

JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, ...

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

A group of researchers developed a promising fix to CRISPR-Cas9's problem with unwanted genetic changes using a method that allows them to turn off gene-editing until it reaches key cell cycle phases ...